Zimmer Biomet Holdings, Inc. operates in the musculoskeletal healthcare sector, providing orthopedic reconstructive products globally. Despite market fluctuations, its diversified product portfolio and strong presence in key healthcare markets offer robust long-term growth potential. Investors should watch for any shifts in healthcare regulations that could impact product demand.
The fundamental analysis provides insights into Zimmer Biomet's financial health and efficiency. Here's a breakdown of their ratings in key categories:
| Category | Score | Visual |
|---|---|---|
| Discounted Cash Flow | 5 | |
| Return on Equity | 3 | |
| Return on Assets | 4 | |
| Debt to Equity | 2 | |
| Price to Earnings | 2 | |
| Price to Book | 4 |
Comparing current and previous scores provides insights into the company's historical performance trend:
| Date | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2026-05-22 | 4 | 5 | 3 | 4 | 2 | 2 | 4 |
| Historical | 0 | 5 | 3 | 4 | 2 | 2 | 4 |
The following table summarizes analyst expectations for future stock prices:
| High | Low | Median | Consensus |
|---|---|---|---|
| $120 | $83 | $93 | $96.33 |
Analyst sentiment around Zimmer Biomet Holdings based on current ratings:
| Recommendation | Count | Visual |
|---|---|---|
| Strong Buy | 0 | |
| Buy | 18 | |
| Hold | 21 | |
| Sell | 3 | |
| Strong Sell | 0 |
Zimmer Biomet Holdings presents a solid investment opportunity within the healthcare device sector, bolstered by a robust product lineup and global presence. While the historical ratings suggest a steady performance, the firm faces challenges related to potential regulatory changes and increased competition. The analyst sentiment indicates mixed views, with a consensus to hold, pointing to potential cautious optimism about future performance. Investors should continue to monitor financial metrics and industry developments closely. Overall, ZBH's position in the market makes it a company to watch for potential long-term gains.
Don't leave your profits to chance. Historically, this stock follows specific seasonal patterns that institutional traders use to maximize returns.